viernes, 6 de octubre de 2017

National Breast Cancer Awareness Month (see related guidelines) 1 | National Guideline Clearinghouse

Search | National Guideline Clearinghouse

ngc



  • GUIDELINE SUMMARY
  •  
  • NGC:010373
  •  
  • 2013 SEP

Optimal use of taxanes in metastatic breast cancer (MBC).

  • GUIDELINE SUMMARY
  •  
  • NGC:010699
  •  
  • 2014 SEP 29

Locoregional therapy of locally advanced breast cancer (LABC).

  • GUIDELINE SUMMARY
  •  
  • NGC:010904
  •  
  • 2016 FEB 16

Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.

  • GUIDELINE SUMMARY
  •  
  • NGC:010705
  •  
  • 2014

WHO position paper on mammography screening.

  • GUIDELINE SUMMARY
  •  
  • NGC:010174
  •  
  • 1996 (REVISED 2013)

ACR Appropriateness Criteria® local-regional recurrence (LRR) and salvage surgery—breast cancer.

  • GUIDELINE SUMMARY
  •  
  • NGC:010391
  •  
  • 2012 MAY

Prevention and treatment of rash in patients treated with EGFR inhibitor therapies.

  • GUIDELINE SUMMARY
  •  
  • NGC:009677
  •  
  • 1996 (REVISED 2012)

ACR Appropriateness Criteria® spinal bone metastases.

  • GUIDELINE SUMMARY
  •  
  • NGC:009206
  •  
  • 2011 JUL (REVISED 2012 JAN)

Care of the HIV-infected transgender patient.

  • GUIDELINE SUMMARY
  •  
  • NGC:009657
  •  
  • 1996 (REVISED 2012)

ACR Appropriateness Criteria® nonpalpable mammographic findings (excluding calcifications).

  • GUIDELINE SUMMARY
  •  
  • NGC:009311
  •  
  • 2012 AUG

Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer.

  • GUIDELINE SUMMARY
  •  
  • NGC:010672
  •  
  • 1996 (REVISED 2014)

ACR Appropriateness Criteria® non-spine bone metastases.

  • GUIDELINE SUMMARY
  •  
  • NGC:009736
  •  
  • 2007 JUN (REVISED 2013 APR)

NSGC practice guideline: risk assessment and genetic counseling for hereditary breast and ovarian cancer.

  • GUIDELINE SUMMARY
  •  
  • NGC:009869
  •  
  • 2013 MAR

Evidence-based clinical practice guideline: breast reconstruction with expanders and implants.

  • GUIDELINE SUMMARY
  •  
  • NGC:010022
  •  
  • 1998 OCT (REVISED 2013 SEP)

Treatment of primary breast cancer. A national clinical guideline.

  • GUIDELINE SUMMARY
  •  
  • NGC:010011
  •  
  • 2013 AUG

Everolimus in combination with exemestane for treating advanced HER2-negative hormone-receptor-positive breast cancer after endocrine therapy.

No hay comentarios:

Publicar un comentario